1. Home
  2. CPRX vs CCOI Comparison

CPRX vs CCOI Comparison

Compare CPRX & CCOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • CCOI
  • Stock Information
  • Founded
  • CPRX 2002
  • CCOI 1999
  • Country
  • CPRX United States
  • CCOI United States
  • Employees
  • CPRX N/A
  • CCOI N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • CCOI Telecommunications Equipment
  • Sector
  • CPRX Health Care
  • CCOI Consumer Discretionary
  • Exchange
  • CPRX Nasdaq
  • CCOI Nasdaq
  • Market Cap
  • CPRX 2.9B
  • CCOI 2.4B
  • IPO Year
  • CPRX 2006
  • CCOI N/A
  • Fundamental
  • Price
  • CPRX $20.78
  • CCOI $50.08
  • Analyst Decision
  • CPRX Strong Buy
  • CCOI Buy
  • Analyst Count
  • CPRX 6
  • CCOI 8
  • Target Price
  • CPRX $32.83
  • CCOI $75.75
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • CCOI 646.7K
  • Earning Date
  • CPRX 08-06-2025
  • CCOI 08-07-2025
  • Dividend Yield
  • CPRX N/A
  • CCOI 8.04%
  • EPS Growth
  • CPRX 178.13
  • CCOI N/A
  • EPS
  • CPRX 1.57
  • CCOI N/A
  • Revenue
  • CPRX $534,645,999.00
  • CCOI $936,884,000.00
  • Revenue This Year
  • CPRX $16.37
  • CCOI $6.83
  • Revenue Next Year
  • CPRX $8.80
  • CCOI $7.84
  • P/E Ratio
  • CPRX $13.34
  • CCOI N/A
  • Revenue Growth
  • CPRX 29.97
  • CCOI N/A
  • 52 Week Low
  • CPRX $15.34
  • CCOI $43.65
  • 52 Week High
  • CPRX $26.58
  • CCOI $86.76
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 38.36
  • CCOI 56.01
  • Support Level
  • CPRX $20.62
  • CCOI $48.88
  • Resistance Level
  • CPRX $22.10
  • CCOI $50.96
  • Average True Range (ATR)
  • CPRX 0.60
  • CCOI 1.31
  • MACD
  • CPRX 0.06
  • CCOI 0.23
  • Stochastic Oscillator
  • CPRX 50.34
  • CCOI 78.35

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About CCOI Cogent Communications Holdings Inc.

Cogent carries over one fifth of the world's internet traffic over its network and is a broadband provider for businesses. Cogent's corporate customers are in high-rise office buildings, where the firm provides two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for nearly half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.

Share on Social Networks: